Hemoglobin Synthesis — MCQs
What is the rate-limiting enzyme in heme synthesis?
A patient's relatives sent a message on social media to the consulting doctor, mentioning that the patient's urinary coproporphyrin test is positive. What is the probable cause?
Which of the following statements about hemoglobin is true?
A girl who developed abdominal pain and presented to the emergency department with a seizure after taking sulphonamides is likely to have a diagnosis of:
How many heme groups are present in a hemoglobin molecule?
Which of the following statements about sickle cell disease is true?
In which type of hemoglobin are zeta 2 and gamma 2 chains present?
Which of the following is not classified as a cutaneous porphyria?
Which porphyrin forms the organic component of heme?
Which poison is most likely to cause megaloblastic anemia?
Hemoglobin Synthesis Indian Medical PG Practice Questions and MCQs
Question 1: What is the rate-limiting enzyme in heme synthesis?
- A. ALA synthase (Correct Answer)
- B. HMG CoA reductase
- C. ALA dehydratase
- D. Uroporphyrinogen 1 synthase
Explanation: ***ALA synthase*** - **Aminolevulinate synthase** (ALA synthase) is the first and **rate-limiting enzyme** in the heme synthesis pathway. - Its activity is tightly regulated, and its overexpression or deficiency can lead to disorders like **acute intermittent porphyria**. *Hmg coa reductase* - **HMG-CoA reductase** is the **rate-limiting enzyme** in the **cholesterol biosynthesis pathway**, not heme synthesis. - It is the target enzyme for statin medications, which lower cholesterol levels. *ALA dehydratase* - **ALA dehydratase** (also known as porphobilinogen synthase) is the second enzyme in the heme synthesis pathway, responsible for converting two molecules of **ALA to porphobilinogen**. - While critical, it is not the rate-limiting step; inhibition of this enzyme can lead to **lead poisoning**. *Uroporphyrinogen 1 synthase* - **Uroporphyrinogen I synthase** (also called hydroxymethylbilane synthase or porphobilinogen deaminase) catalyzes the formation of **hydroxymethylbilane** from four molecules of **porphobilinogen**. - A deficiency in this enzyme is associated with **acute intermittent porphyria**, but it is not the rate-limiting enzyme of the overall pathway.
Question 2: A patient's relatives sent a message on social media to the consulting doctor, mentioning that the patient's urinary coproporphyrin test is positive. What is the probable cause?
- A. Lead poisoning (Correct Answer)
- B. Asbestosis
- C. Silicosis
- D. Mercury poisoning
- E. Arsenic poisoning
Explanation: ***Lead poisoning*** - **Lead poisoning** is associated with an increase in **urinary coproporphyrin III**, as lead inhibits the enzyme **coproporphyrinogen oxidase** in the heme synthesis pathway. - This leads to the accumulation and excretion of **coproporphyrin III** in the urine, making it a valuable biomarker for lead exposure. *Asbestosis* - **Asbestosis** is a chronic lung disease caused by inhaling **asbestos fibers**, leading to diffuse interstitial fibrosis. - It does not directly affect the **heme synthesis pathway** or cause an increase in urinary coproporphyrins. *Silicosis* - **Silicosis** is a chronic occupational lung disease caused by inhaling **crystalline silica dust**, resulting in pulmonary fibrosis. - It is not associated with alterations in **porphyrin metabolism** or increased urinary coproporphyrin levels. *Mercury poisoning* - While **mercury poisoning** can affect various organ systems, including renal and neurological, it is not primarily associated with disturbances in the **heme synthesis pathway** or elevated urinary coproporphyrins. - **Mercury poisoning** often manifests with symptoms like **tremors**, **neurological deficits**, and **kidney damage**. *Arsenic poisoning* - **Arsenic poisoning** causes a variety of systemic effects including gastrointestinal symptoms, peripheral neuropathy, and skin changes (hyperpigmentation, hyperkeratosis). - Unlike lead poisoning, **arsenic does not significantly elevate urinary coproporphyrin III** levels, making it distinguishable from lead toxicity through this biomarker.
Question 3: Which of the following statements about hemoglobin is true?
- A. Each hemoglobin molecule can bind up to six O2 molecules.
- B. Each hemoglobin subunit contains two heme groups, which bind oxygen.
- C. Hemoglobin consists of two alpha and two beta subunits, each capable of binding one O2 molecule. (Correct Answer)
- D. Each hemoglobin molecule is made of 6 polypeptide chains.
Explanation: ***Hemoglobin consists of two alpha and two beta subunits, each capable of binding one O2 molecule.*** - A **hemoglobin molecule is a tetramer**, meaning it is composed of four protein subunits: two alpha (α) chains and two beta (β) chains. - Each of these four subunits contains one **heme group**, which is an iron-containing porphyrin complex that can reversibly bind one molecule of **oxygen (O2)**. *Each hemoglobin molecule can bind up to six O2 molecules.* - A single hemoglobin molecule, with its **four heme groups**, can bind a maximum of **four O2 molecules**, not six. - The capacity for oxygen binding is directly proportional to the number of heme groups present in the hemoglobin molecule. *Each hemoglobin subunit contains two heme groups, which bind oxygen.* - Each individual **hemoglobin subunit (alpha or beta)** contains **only one heme group**, not two. - Therefore, a complete hemoglobin molecule (with four subunits) contains a total of four heme groups. *Each hemoglobin molecule is made of 6 polypeptides, one for each subunit.* - A hemoglobin molecule is composed of **four polypeptide chains** (two alpha and two beta), not six. - This tetrameric structure is crucial for its function and **cooperative oxygen binding**.
Question 4: A girl who developed abdominal pain and presented to the emergency department with a seizure after taking sulphonamides is likely to have a diagnosis of:
- A. Acute intermittent porphyria due to other triggers (Correct Answer)
- B. Congenital erythropoietic porphyria with skin manifestations
- C. Infectious mononucleosis with fever and lymphadenopathy
- D. Kawasaki disease with prolonged fever and rash
Explanation: ***Acute intermittent porphyria due to other triggers*** - The combination of **abdominal pain**, **seizure**, and the **ingestion of sulfonamides** (a known trigger) is highly suggestive of an acute porphyric attack [1]. - **Sulfonamides** induce δ-aminolevulinate synthase, leading to an overproduction of neurotoxic porphyrin precursors [1]. *Congenital erythropoietic porphyria with skin manifestations* - This condition primarily presents with **severe photosensitivity**, **blistering skin lesions**, and **hemolytic anemia**, rather than acute neurological symptoms [1]. - While it is a type of porphyria, its clinical presentation and triggers are distinct from the neurovisceral symptoms described. *Infectious mononucleosis with fever and lymphadenopathy* - Characterized by **fever**, **fatigue**, **sore throat**, and **lymphadenopathy**, symptoms not aligned with the severe abdominal pain and seizure observed. - This condition is caused by the Epstein-Barr virus and is not triggered by sulfonamide use. *Kawasaki disease with prolonged fever and rash* - This is an **acute vasculitis** in children, involving **prolonged fever**, **rash**, **conjunctivitis**, and lymphadenopathy, but not seizures or abdominal pain caused by sulfonamides. - It primarily affects the cardiovascular system and is not related to porphyria or drug-induced attacks.
Question 5: How many heme groups are present in a hemoglobin molecule?
- A. 2
- B. 3
- C. 1
- D. 4 (Correct Answer)
Explanation: ***4*** - A **hemoglobin molecule** is composed of **four polypeptide chains** (typically two alpha and two beta subunits). - Each of these four polypeptide chains contains **one heme group**, making a total of **four heme groups per hemoglobin molecule**. - The quaternary structure of hemoglobin as a **tetramer** allows it to efficiently bind and transport oxygen. *1* - This number represents the heme groups found in a single **myoglobin molecule**, which is a monomeric protein with only one polypeptide chain. - Hemoglobin, however, is a **tetramer** with four subunits, each containing one heme group. *2* - This number is incorrect and does not correspond to the structure of hemoglobin. - Hemoglobin requires **four heme groups** (one per subunit) to function efficiently as an oxygen transporter with cooperative binding. *3* - This number is incorrect; the symmetrical quaternary structure of hemoglobin consists of **four subunits**, not three. - Each subunit contains one heme group as a prosthetic group, resulting in a total of four heme groups per hemoglobin molecule.
Question 6: Which of the following statements about sickle cell disease is true?
- A. Sickling is completely reversible with oxygenation, making it clinically insignificant.
- B. Sickling leads to a significant increase in overall MCHC levels in the blood.
- C. Fetal hemoglobin inhibits sickling. (Correct Answer)
- D. Sickling occurs exclusively in the homozygous state and never in the heterozygous state.
Explanation: ***Sickling is reversible with oxygenation*** - When oxygen tension is restored, hemoglobin S can re-hydrate and revert to its normal shape, reducing sickling. - This reversible process is essential for managing episodes of vaso-occlusive crisis in sickle cell disease. *Fetal hemoglobin facilitates Sickling* - Fetal hemoglobin (HbF) actually inhibits sickling by stabilizing the erythrocyte shape and reducing the proportion of hemoglobin S [1]. - Individuals with higher levels of HbF experience fewer sickling-related complications [1]. *Sickling occurs both in heterozygous and homozygous state* - Sickling primarily occurs in the homozygous state (HbSS); heterozygotes (HbAS) usually do not experience significant sickling effects [1]. - Heterozygous individuals may have a selective advantage against malaria, but they are not prone to sickle cell crises. *Sickling Leads to decreased MCHC* - Sickling does not directly lead to decreased mean corpuscular hemoglobin concentration (MCHC); MCHC is typically normal in sickle cell patients. - In fact, sickle cell disease often results in hemolysis and can lead to increased MCHC in some cases.
Question 7: In which type of hemoglobin are zeta 2 and gamma 2 chains present?
- A. Gower I
- B. Gower II
- C. Portland (Correct Answer)
- D. Fetal hemoglobin
Explanation: ***Portland*** - **Portland hemoglobin** is a primitive embryonic hemoglobin composed of **zeta (ζ) 2 and gamma (γ) 2 chains** (ζ2γ2). - It plays a role in early fetal oxygen transport, particularly in the yolk sac stage. *Gower I* - **Gower I hemoglobin** is another embryonic hemoglobin, but it consists of **zeta (ζ) 2 and epsilon (ε) 2 chains** (ζ2ε2). - This composition is crucial for oxygen delivery during the very initial stages of embryonic development. *Gower II* - **Gower II hemoglobin** is an embryonic hemoglobin made up of **alpha (α) 2 and epsilon (ε) 2 chains** (α2ε2). - It represents a transitional form as the embryo develops and starts producing alpha globin chains. *Fetal hemoglobin* - **Fetal hemoglobin (HbF)** consists of **alpha (α) 2 and gamma (γ) 2 chains** (α2γ2). - It is the predominant hemoglobin during the second and third trimesters of pregnancy and has a higher affinity for oxygen than adult hemoglobin.
Question 8: Which of the following is not classified as a cutaneous porphyria?
- A. Congenital erythropoietic porphyria
- B. Erythropoietic protoporphyria
- C. Sideroblastic anemia (Correct Answer)
- D. Hereditary coproporphyria
Explanation: ***Hereditary coproporphyria*** - This condition is primarily associated with **acute episodes** and **neuropathy**, rather than cutaneous manifestations. [2] - Unlike cutaneous porphyrias, symptoms are more systemic and do not commonly present with **skin lesions**. Although skin features can occur in some instances, they mimic porphyria cutanea tarda. [2] *Congenital erythropoeitic porphyria* - Characterized by severe **cutaneous symptoms** such as blistering and photosensitivity due to **skin exposure**. - Patients exhibit notable **facial disfigurement** and can have **hemolytic anemia**, aligning it clearly with the cutaneous forms of porphyria. *Sideroblastic anemia* - This condition involves issues with **hemoglobin synthesis** and does not fit the porphyria classification. [1] - It primarily presents with **microcytic anemia**, and the symptoms are primarily hematological, not cutaneous. [1] *Erythropoeitic porphyria* - Characterized by **severe photosensitivity** and skin manifestations, similar to congenital erythropoeitic porphyria. [1] - Patients may develop **blisters** and **hyperpigmentation** upon sun exposure, categorizing it among cutaneous porphyrias. [2]
Question 9: Which porphyrin forms the organic component of heme?
- A. Uroporphyrin
- B. Coproporphyrin
- C. Deuteroporphyrin
- D. Protoporphyrin IX (Correct Answer)
Explanation: ***Protoporphyrin IX*** - **Heme** is formed by the insertion of an **iron atom (Fe2+)** into the center of **protoporphyrin IX**. - **Protoporphyrin IX** is the immediate precursor to heme in the **heme synthesis pathway**. *Uroporphyrin* - **Uroporphyrin** is an earlier precursor in the **heme synthesis pathway** and is much more hydrophilic than protoporphyrin. - It accumulates in diseases like **congenital erythropoietic porphyria (CEP)**, leading to photosensitivity. *Coproporphyrin* - **Coproporphyrin** is an intermediate in the **heme synthesis pathway**, formed after uroporphyrinogen. - It is also more water-soluble than protoporphyrin and its accumulation can be seen in various porphyrias. *Deuteroporphyrin* - **Deuteroporphyrin** is a synthetic porphyrin or a less common natural porphyrin that is not directly involved as the organic component of heme in mammals. - While it is structurally similar to protoporphyrin, it does not serve as the direct precursor for heme formation in the human body.
Question 10: Which poison is most likely to cause megaloblastic anemia?
- A. Copper
- B. Lead
- C. Mercury
- D. Arsenic (Correct Answer)
Explanation: ***Arsenic*** - **Arsenic poisoning** can cause various hematological abnormalities, and in chronic exposure, it may interfere with **folate metabolism** and **DNA synthesis**, potentially leading to **megaloblastic anemia**. - While **aplastic anemia** and **hemolytic anemia** are more commonly associated with arsenic toxicity, megaloblastic changes can occur due to disruption of normal erythrocyte maturation. - Among the given options, arsenic has the strongest association with megaloblastic anemia, though this is **not the most common hematological manifestation** of arsenic poisoning. *Copper* - **Copper deficiency** causes **microcytic hypochromic anemia** (similar to iron deficiency) due to impaired iron metabolism. - **Copper toxicity** (Wilson's disease) may cause **hemolytic anemia** but not megaloblastic anemia. *Lead* - **Lead poisoning** characteristically causes **sideroblastic anemia** with **basophilic stippling** of RBCs. - Lead inhibits enzymes in heme synthesis pathway, leading to accumulation of iron in mitochondria. - Does **not** cause the macrocytic changes seen in megaloblastic anemia. *Mercury* - **Mercury poisoning** primarily causes **neurotoxicity** (tremors, cognitive impairment, ataxia) and **nephrotoxicity**. - Not associated with megaloblastic anemia; any anemia is typically secondary to chronic disease or renal dysfunction.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free